tirzepatide in ghana Replying to @TIRZEPATIDE VENDOR Lilly eyes weight loss arena

RetaLABS Tirzepatide 30mg is a lyophilised research vial of LY3298176, a dual GLP-1 and GIP receptor agonist developed by Eli Lilly, the first compound in the "twincretin" class

The FDA-approved titration schedule begins at 2.5 mg weekly for four weeks, primarily as a tolerability dose rather than a therapeutic dose

These numbers matter because every 5 mmHg reduction in systolic blood pressure correlates with approximately a 10% reduction in major cardiovascular events

Additionally, fluctuations in blood sugar levels can affect tear production and corneal health

December 5, 2025

Summary: Light-headedness after Mounjaro occurs through blood glucose changes, blood pressure reductions, and dehydration from gastrointestinal side effects, typically during initial treatment or dose escalation